Photo from Flavia Jacobs/LinkedIn
Oct 7, 2024, 12:47
Flavia Jacobs: Great advanced ESMO course on Antibody-Drug Conjugates
Flavia Jacobs, Medical Research Fellow at Institute Jules Bordet, recently shared on LinkedIn:
“Great advanced ESMO course on Antibody-Drug Conjugates focused on breast, gastrointestinal and gynecologic cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 1, 2025, 10:57
Mar 1, 2025, 10:17
Mar 1, 2025, 09:24
Mar 1, 2025, 09:12
Mar 1, 2025, 08:45
Mar 1, 2025, 08:32
Mar 1, 2025, 08:26
Mar 1, 2025, 02:20
Feb 28, 2025, 18:34
Humanitas delegation is present.”Alberto Puccini shared this post adding:
“A truly outstanding course with excellent lectures from key opinion leaders! Exciting to see such rapid and extensive development of new drugs with new treatment options for our patients!
Thanks to ESMO – European Society for Medical Oncology and to the extraordinary faculty for this amazing opportunity!”
Source: Flavia Jacobs/LinkedIn and Alberto Puccini/LinkedIn
Alberto Puccini is a Medical Oncologist at the Humanitas Cancer Center and a fixed-term researcher (RTDA – Assistant Professor) at Humanitas University. His skills and expertise include colorectal cancer, translational cancer research, cancer biomarkers, and medical oncology.